Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 5Inflammatory Bowel Diseases 2Colitis, Ulcerative 2Spondylitis, Ankylosing 1Psoriasis 1Precancerous Conditions 1Melanoma 1Infections 1Hepatitis C 1Crohn Disease 1Arthritis 1

Interventions

ziprasidone 1tocilizumab 1talquetamab 1idecabtagene vicleucel 1golimumab 1gilteritinib 1anifrolumab 1Zolpidem 1X-Rays 1Wearable Electronic Devices 1Watchful Waiting 1Warfarin 1Vital Signs 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factor Inhibitors 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Rituximab 1Procalcitonin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Infections × Infliximab × Clear all
NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡